Campus News

August 08, 2012
There is no cure for multiple sclerosis, but several medications can help slow its devastating effects, and extend healthier years for the roughly 2.5 million people worldwide diagnosed with this chronic neurological disease.
May 20, 2012
UCSF scientists have shown that a key brain structure in the Bengalese finch acts as a learning hub, receiving information that helps to improve its song, a finding which may lead to new ways to treat neurological disorders that impair movement such as Parkinson’s disease.
March 27, 2012
The UCSF community is invited to hear Allan Basbaum's lecture, “The Neurological Basis of Pain and Its Control,” on April 17 as part of the Second Annual Faculty Research Lecture in Translational Science.
January 18, 2012
Dogs with spinal cord injuries may soon benefit from an experimental drug being tested by researchers at UCSF and Texas A&M College of Veterinary Medicine & Biomedical Sciences — work that they hope will one day help people with similar injuries.
November 14, 2011
UCSF scientists Anatol Kreitzer, PhD, and Loren Frank, PhD, have won and will share the prestigious 2011 Young Investigator Award from the Society for Neuroscience. 
November 01, 2011
An experimental drug called Ocrelizumab has shown promise in a Phase 2 clinical trial involving 220 people with multiple sclerosis (MS), an often debilitating, chronic autoimmune disease that affects an increasing number of people in North America.
October 26, 2011
The widow of the late Sen. Edward M. Kennedy joined a UCSF panel of caregivers and clinicians who recently explored ways of enhancing the quality of life and care of brain cancer patients.
October 24, 2011
A study by researchers at the University of Mississippi Medical Center and UCSF shows that rats given a popularly prescribed antidepressant during development exhibit brain abnormalities and behaviors characteristic of autism spectrum disorders.
October 19, 2011
Premature infants exposed after birth to drugs known as glucocorticoids are at increased risk for having impaired growth of the cerebellum, according to findings from a new UCSF-led study. The cerebellum is a region of the brain associated with balance, motor learning, language and behavior.
October 14, 2011
The only medication currently approved for stroke treatment – tissue plasminogen activator (tPA), which dissolves blood clots – is associated with an increased risk of bleeding in the brain, particularly among patients with hyperglycemia (high blood sugar).

Pages